Skip to main content
Erschienen in: Medical Oncology 1/2012

01.03.2012 | Letter to the Editor

Significance of microsatellite instability (MSI) for colorectal cancer following adjuvant therapy with doxifluridine

verfasst von: Toshiaki Watanabe, Keiji Matsuda, Soichiro Ishihara, Keijiro Nozawa, Tamuro Hayama, Hideki Yamada, Hisae Iinuma

Erschienen in: Medical Oncology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

Letter to Editor …
Literatur
1.
Zurück zum Zitat Kang BW, Kim JG, Lee SJ, Chae YS, Moon JH, Sohn SK, et al. Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine. Med Oncol. 16 Oct 2010 [Epub ahead of print]. Kang BW, Kim JG, Lee SJ, Chae YS, Moon JH, Sohn SK, et al. Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine. Med Oncol. 16 Oct 2010 [Epub ahead of print].
2.
Zurück zum Zitat Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001;344:1196–206.PubMedCrossRef Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001;344:1196–206.PubMedCrossRef
3.
Zurück zum Zitat Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247–57.PubMedCrossRef Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247–57.PubMedCrossRef
Metadaten
Titel
Significance of microsatellite instability (MSI) for colorectal cancer following adjuvant therapy with doxifluridine
verfasst von
Toshiaki Watanabe
Keiji Matsuda
Soichiro Ishihara
Keijiro Nozawa
Tamuro Hayama
Hideki Yamada
Hisae Iinuma
Publikationsdatum
01.03.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9799-2

Weitere Artikel der Ausgabe 1/2012

Medical Oncology 1/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.